A key focus for PTX is CAR-T. They announced a partnership, but have not been able to disclose anything yet. If you watch the interviews with the CEO, he hints that PTX is enabling pathways for CAR-T to target a diverse cancer set, where previously CAR-T is very limited. Very similar to the announcement you have provided.
This company is extremely interesting, they are on the bleeding edge of cancer treatments, a diversified portfolio, multiple pathways to blockbuster status. All very risky as is the nature of BIO's. I am looking forward to seeing where this company goes in the next 12 months.
- Forums
- ASX - By Stock
- Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
A key focus for PTX is CAR-T. They announced a partnership, but...
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
0.002(4.44%) |
Mkt cap ! $37.85M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.7¢ | $120 | 2.553K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 47447 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.046 |
2 | 219999 | 0.045 |
2 | 239841 | 0.044 |
3 | 657800 | 0.043 |
6 | 304523 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 47447 | 1 |
0.048 | 170000 | 2 |
0.049 | 114091 | 2 |
0.050 | 331300 | 6 |
0.052 | 500000 | 1 |
Last trade - 10.08am 09/09/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |